CN115500315B - Construction method and application of father-source cognitive disorder animal model - Google Patents
Construction method and application of father-source cognitive disorder animal model Download PDFInfo
- Publication number
- CN115500315B CN115500315B CN202210861165.2A CN202210861165A CN115500315B CN 115500315 B CN115500315 B CN 115500315B CN 202210861165 A CN202210861165 A CN 202210861165A CN 115500315 B CN115500315 B CN 115500315B
- Authority
- CN
- China
- Prior art keywords
- mice
- father
- cognitive impairment
- animal model
- offspring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 208000010877 cognitive disease Diseases 0.000 title claims abstract description 65
- 238000010171 animal model Methods 0.000 title claims abstract description 26
- 238000010276 construction Methods 0.000 title claims abstract description 17
- 241000699670 Mus sp. Species 0.000 claims abstract description 108
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 48
- 229910052793 cadmium Inorganic materials 0.000 claims abstract description 38
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 235000009200 high fat diet Nutrition 0.000 claims abstract description 35
- 238000011282 treatment Methods 0.000 claims abstract description 32
- 230000000971 hippocampal effect Effects 0.000 claims abstract description 26
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 18
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 18
- 230000001575 pathological effect Effects 0.000 claims abstract description 11
- 230000002265 prevention Effects 0.000 claims abstract description 8
- 235000005911 diet Nutrition 0.000 claims abstract description 7
- 230000037213 diet Effects 0.000 claims abstract description 7
- 230000000946 synaptic effect Effects 0.000 claims abstract description 6
- 208000028698 Cognitive impairment Diseases 0.000 claims description 41
- 238000002474 experimental method Methods 0.000 claims description 38
- 238000010186 staining Methods 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 21
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 17
- YKYOUMDCQGMQQO-UHFFFAOYSA-L cadmium dichloride Chemical compound Cl[Cd]Cl YKYOUMDCQGMQQO-UHFFFAOYSA-L 0.000 claims description 12
- 238000012347 Morris Water Maze Methods 0.000 claims description 11
- 102000004219 Brain-derived neurotrophic factor Human genes 0.000 claims description 10
- 108090000715 Brain-derived neurotrophic factor Proteins 0.000 claims description 10
- 102000047174 Disks Large Homolog 4 Human genes 0.000 claims description 10
- 108700019745 Disks Large Homolog 4 Proteins 0.000 claims description 10
- 101150069842 dlg4 gene Proteins 0.000 claims description 10
- 201000010099 disease Diseases 0.000 claims description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 9
- 238000012360 testing method Methods 0.000 claims description 8
- 102000017299 Synapsin-1 Human genes 0.000 claims description 7
- 108050005241 Synapsin-1 Proteins 0.000 claims description 7
- 230000003542 behavioural effect Effects 0.000 claims description 7
- 238000009395 breeding Methods 0.000 claims description 6
- 230000001488 breeding effect Effects 0.000 claims description 6
- 238000003745 diagnosis Methods 0.000 claims description 6
- 231100001238 environmental toxicant Toxicity 0.000 claims description 5
- 230000006651 lactation Effects 0.000 claims description 5
- 238000011814 C57BL/6N mouse Methods 0.000 claims description 4
- 238000009227 behaviour therapy Methods 0.000 claims description 4
- 238000001514 detection method Methods 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 229940126585 therapeutic drug Drugs 0.000 claims description 4
- 101000831205 Danio rerio Dynein axonemal assembly factor 11 Proteins 0.000 claims description 3
- 102100024282 Dynein axonemal assembly factor 11 Human genes 0.000 claims description 3
- 241001559542 Hippocampus hippocampus Species 0.000 claims description 3
- 101000831210 Homo sapiens Dynein axonemal assembly factor 11 Proteins 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 3
- 230000037208 balanced nutrition Effects 0.000 claims description 3
- 235000019046 balanced nutrition Nutrition 0.000 claims description 3
- 230000013011 mating Effects 0.000 claims description 3
- 238000000926 separation method Methods 0.000 claims description 3
- 206010002091 Anaesthesia Diseases 0.000 claims description 2
- 230000037005 anaesthesia Effects 0.000 claims description 2
- 230000010534 mechanism of action Effects 0.000 claims description 2
- 230000000284 resting effect Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 235000021590 normal diet Nutrition 0.000 claims 1
- 230000013016 learning Effects 0.000 abstract description 10
- 230000015654 memory Effects 0.000 abstract description 10
- 230000006378 damage Effects 0.000 abstract description 7
- 239000004029 environmental poison Substances 0.000 abstract description 6
- 230000009471 action Effects 0.000 abstract description 5
- 239000002131 composite material Substances 0.000 abstract description 5
- 230000007246 mechanism Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 210000002569 neuron Anatomy 0.000 description 24
- 230000000694 effects Effects 0.000 description 15
- 210000001519 tissue Anatomy 0.000 description 15
- 235000015263 low fat diet Nutrition 0.000 description 14
- 210000001320 hippocampus Anatomy 0.000 description 9
- 210000003520 dendritic spine Anatomy 0.000 description 8
- 210000004295 hippocampal neuron Anatomy 0.000 description 8
- 230000003920 cognitive function Effects 0.000 description 7
- 230000006886 spatial memory Effects 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 210000004379 membrane Anatomy 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 235000008242 dietary patterns Nutrition 0.000 description 4
- 238000004043 dyeing Methods 0.000 description 4
- 210000000225 synapse Anatomy 0.000 description 4
- 239000008096 xylene Substances 0.000 description 4
- 239000002033 PVDF binder Substances 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 235000004213 low-fat Nutrition 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 206010012289 Dementia Diseases 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 101100259948 Mus musculus Tbata gene Proteins 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000005013 brain tissue Anatomy 0.000 description 2
- 238000011284 combination treatment Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000006386 memory function Effects 0.000 description 2
- 230000001537 neural effect Effects 0.000 description 2
- 230000004766 neurogenesis Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 230000005180 public health Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000031836 visual learning Effects 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- FYHRJWMENCALJY-YSQMORBQSA-N (25R)-cholest-5-ene-3beta,26-diol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCC[C@H](CO)C)[C@@]1(C)CC2 FYHRJWMENCALJY-YSQMORBQSA-N 0.000 description 1
- DKISDYAXCJJSLZ-UHFFFAOYSA-N 26-Hydroxy-cholesterin Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(CO)C)C1(C)CC2 DKISDYAXCJJSLZ-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000895503 Metrosideros Species 0.000 description 1
- 206010053632 Reactive psychosis Diseases 0.000 description 1
- ZHAFUINZIZIXFC-UHFFFAOYSA-N [9-(dimethylamino)-10-methylbenzo[a]phenoxazin-5-ylidene]azanium;chloride Chemical compound [Cl-].O1C2=CC(=[NH2+])C3=CC=CC=C3C2=NC2=C1C=C(N(C)C)C(C)=C2 ZHAFUINZIZIXFC-UHFFFAOYSA-N 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- 208000015114 central nervous system disease Diseases 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000002060 circadian Effects 0.000 description 1
- 210000001787 dendrite Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 230000007787 long-term memory Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 235000020183 skimmed milk Nutrition 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000003956 synaptic plasticity Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/02—Breeding vertebrates
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The application relates to the technical field of animal model construction, and discloses a construction method and application of a father cognitive disorder animal model. The application has the beneficial effects that: through combined treatment of father mice high-fat diet and cadmium water exposure, offspring mice have reduced learning and memory capacity, hippocampal pathological damage and synaptic related protein level, the father cognitive disorder model is successfully established, the father cognitive disorder model can be used for simulating a composite exposure mode of human environmental poison and diet, the action mechanism and treatment targets of the father cognitive disorder are explored, targeted treatment drugs of the father cognitive disorder are screened, and important basis is provided for formulating early prevention strategies of the father cognitive disorder in the future.
Description
Technical Field
The application relates to the technical field of animal model construction, in particular to a construction method and application of a parent cognitive impairment animal model.
Background
Cognitive impairment is a neurodegenerative disease that manifests as reduced learning and memory, and mainly includes dementia, reactive psychosis, and the like. In recent years, global dementia has increased year by year. This not only brings great disease burden to the family of patients, but also brings heavy burden to the public health and the old health care system in China. Thus, cognitive impairment has become a significant medical and public health problem in China and even worldwide.
Currently, the major risk factors for cognitive impairment include environmental poison exposure, altered eating patterns, and the like [5] . Cadmium is a toxic heavy metal that is widely present in the environment. Epidemiological studies have shown that urinary cadmium concentration is inversely related to cognitive function; animal studies have further demonstrated that contemporary environmental cadmium exposure can cause cognitive dysfunction [6-7] . Furthermore, with the increasing level of our daily lives, high-fat diets are becoming more common, and population and animal studies indicate that contemporary high-fat diets may lead to reduced cognitive function [8-9] . However, most of the past studies were single factor exposure in contemporary environments. In a real world environment, it is common for a variety of environmental factors to coexist and be exposed to the body. And in recent years, the theory of health and disease father origin (POHaD) believes that exposure of father-to-bad factors may increase the risk of adult chronic disease in offspring [10-11] . A recent study showed that father high-fat diet caused a reduction in cognitive function levels in offspring [12] . This study suggests that cognitive impairment may present with a parent etiology.
However, current animal models of cognitive disorders are contemporary and single factor treatments, such as mice exhibiting reduced spatial memory capacity following exposure to contemporary dioctyl phthalate or 27-hydroxycholesterol [13-14] . Although these modeling methods can simulate disease models in which cognitive impairment occurs, the models are poor in stability and fail to truly reflect the human complex exposure pattern, which is inconsistent with the parental pathogenesis. Therefore, the existing research is urgent to establish a stable and father-source model of cognitive impairment of mice consistent with the complex exposure mode of human environmental toxicants and diets, and to screen possible risk factors therefrom, thereby performing early prevention and control on the risk factors and promoting human beingsAnd (5) health-like.
[ reference ] to
1.Ritchie K,Lovestone S.The dementias.The Lancet.2002；360(9347):1759-1766.
2.Jia L,Quan M,Fu Y,Zhao T,Li Y,Wei C,Tang Y,Qin Q,Wang F,Qiao Y,Shi S,Wang YJ,Du Y,Zhang J,Zhang J,Luo B,Qu Q,Zhou C,Gauthier S,Jia J；Group for the Project of Dementia Situation in China.Dementia in China:epidemiology,clinical management,and research advances.Lancet Neurol.2020；19(1):81-92.
3.Gale SA,Acar D,Daffner KR.Dementia.Am J Med.2018；131(10):1161-1169.
4.Deng Y,Zhao S,Cheng G,et al.The Prevalence of Mild Cognitive Impairment among Chinese People:A Meta-Analysis.Neuroepidemiology.2021；55(2):79-91.
5.Silva MVF,Loures CMG,Alves LCV,de Souza LC,Borges KBG,Carvalho MDG. Alzheimer's disease:risk factors and potentially protective measures.J Biomed Sci.2019； 26(1):33.
6.Gustin K,Tofail F,Vahter M,Kippler M.Cadmium exposure and cognitive abilities and behavior at 10years of age:A prospective cohort study.Environ Int.2018；113:259-268.
7.Wang H,Abel GM,Storm DR,Xia Z.Adolescent cadmium exposure impairs cognition and hippocampal neurogenesis in C57BL/6 mice.Environ Toxicol.2022；37(2):335-348.
8.Hoscheidt S,Sanderlin AH,Baker LD,et al.Mediterranean and Western diet effects on Alzheimer's disease biomarkers,cerebral perfusion,and cognition in mid-life:A randomized trial.Alzheimers Dement.2022；18(3):457-468.
9.Yang Y,Zhong Z,Wang B,et al.Early-life high-fat diet-induced obesity programs hippocampal development and cognitive functions via regulation of gut commensal Akkermansia muciniphila.Neuropsychopharmacology.2019；44(12):2054-2064.
10.Soubry A.Epigenetics as a Driver of Developmental Origins of Health and Disease:Did We Forget the FathersBioessays.2018；40(1):10.
11.Soubry A.POHaD:why we should study future fathers.Environ Epigenet.2018；4(2): dvy007.
12.Zhou Y,Zhu H,Wu HY,et al.Diet-Induced Paternal Obesity Impairs Cognitive Function in Offspring by Mediating Epigenetic Modifications in Spermatozoa.Obesity(Silver Spring).2018；26(11):1749-1757.
13.Wang Y,An Y,Ma W,et al.27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.J Neuroinflammation.2020；17(1):199.
14.Lv J,Li Y,Chen J,et al.Maternal exposure to bis(2-ethylhexyl)phthalate during the thyroid hormone-dependent stage induces persistent emotional and cognitive impairment in middle-aged offspring mice.Food Chem Toxicol.2022；163:112967.
Disclosure of Invention
The technical problem to be solved by the application is how to provide a construction method of a father source cognitive impairment animal model, which has the advantages of high success rate, effectiveness, reliability, strong repeatability, simplicity and easiness.
The application solves the technical problems by the following technical means:
the first aspect of the application provides a construction method and application of a parent cognitive impairment animal model, wherein the construction method comprises the following steps:
(1) Selecting healthy male mice of 4-6 weeks old, randomly grouping, respectively carrying out combined treatment of low-fat diet, cadmium water exposure, high-fat diet and cadmium water exposure, and mating with normal female mice after 9-11 weeks;
(2) The female pregnant mice which are successfully mated are normally eaten and naturally delivered, the produced offspring mice are fed to the lactation period of 4 weeks, then the female pregnant mice are subjected to male-female cage separation and weaning, and are naturally fed according to the normal eating;
(3) Naturally breeding the offspring mice to 14-15 weeks old, and performing a behavioural experiment on the offspring mice; resting for 1-2 weeks after the behavioural experiment is finished, and carrying out anesthesia and sacrifice on offspring mice, taking sea horse tissues for pathological examination and molecular biology experiment, so as to judge the occurrence of cognitive dysfunction.
The beneficial effects are that: the modeling method is simple and easy to implement, the occurrence of the cognitive impairment of the mice is verified together through a plurality of indexes of a behavioral experiment, a pathological examination and a molecular biological experiment, the repeatability is high, and a reliable method is provided for the construction of a father cognitive impairment model.
Preferably, the low fat diet group mice in the step (1) consume 10% kcal of low fat feed, and the high fat diet group mice consume 60% kcal of high fat feed.
Preferably, the cadmium water in the cadmium water exposure group in the step (1) adopts a cadmium chloride aqueous solution, and the concentration of the cadmium chloride is 95-105 mg/L.
Preferably, the male mice and female mice in the step (1) are SPF class C57BL/6N mice; and the male mice and the female mice are mated according to the proportion of 2:3-5.
Preferably, the offspring mice produced in the step (2) are adjusted to have the same number of male mice and female mice per litter on days 3-5 after birth and are fed in a lactation mode so as to ensure balanced nutrition of the mice.
Preferably, the behavioral test is Morris water maze, the pathological examination and molecular biological test comprises mouse hippocampal hematoxylin-eosin staining, nile staining, golgi staining and detection of levels of synapse-related proteins including PSD95, synagin-1 and BDNF, and the cognitive impairment of the mice is determined comprehensively by the behavioral test and the pathological examination and molecular biological test.
The second aspect of the application provides application of the parent cognitive impairment animal model constructed by the construction method.
Preferably, the parent cognitive impairment animal model is applied to simulate the composite exposure mode of human environmental poison and diet and explore the action mechanism and treatment targets of the parent cognitive impairment, and the application aims at diagnosis or treatment of non-diseases.
Preferably, the parenchymal cognitive disorder animal model is applied to the future establishment of an early prevention strategy of the parenchymal cognitive disorder, and the application aims at diagnosis or treatment of non-diseases.
Preferably, the parenchymal cognitive disorder animal model is applied to targeted therapeutic drugs for screening the parenchymal cognitive disorder in the future, and the application aims at diagnosis or treatment of non-diseases.
The beneficial effects are that: the parental cognitive impairment model constructed by the application can be further used for simulating a composite exposure mode of human environmental poison and diet, exploring the action mechanism and the treatment target of the parental cognitive impairment, screening the targeted therapeutic drugs of the parental cognitive impairment, and providing important basis for formulating an early prevention strategy of the parental cognitive impairment in the future.
The application has the advantages that:
1. the modeling method is simple and easy to implement, the occurrence of the cognitive impairment of the mice is verified together through a plurality of indexes of a behavioral experiment, a pathological examination and a molecular biological experiment, the repeatability is high, and a reliable method is provided for the construction of a father cognitive impairment model;
2. the parental cognitive impairment model constructed by the application can be further used for simulating a composite exposure mode of human environmental poison and diet, exploring the action mechanism and the treatment target of the parental cognitive impairment, screening the targeted therapeutic drugs of the parental cognitive impairment, and providing important basis for formulating an early prevention strategy of the parental cognitive impairment in the future.
Drawings
FIG. 1 is a graph showing the results of Morris water maze test on offspring mice in example 1 of the present application.
FIG. 2 is a graph showing the result of hematoxylin-eosin staining of hippocampal tissue of a offspring mouse in example 1 of the present application.
FIG. 3 is a graph showing the result of Nib staining of hippocampal tissue of a offspring mouse in example 1 of the present application.
FIG. 4 is a graph showing the result of Golgi staining of hippocampal tissue of a offspring mouse in example 1 of the present application.
FIG. 5 is a graph showing the results of detection of levels of synapse-associated proteins in hippocampal tissue of a offspring mouse in example 1 of the present application.
Detailed Description
For the purpose of making the objects, technical solutions and advantages of the embodiments of the present application more apparent, the technical solutions in the embodiments of the present application will be clearly and completely described in the following in conjunction with the embodiments of the present application, and it is apparent that the described embodiments are some embodiments of the present application, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the application without making any inventive effort, are intended to be within the scope of the application.
The test materials, reagents and the like used in the examples described below are commercially available unless otherwise specified.
Those of skill in the art, without any particular mention of the techniques or conditions, may follow the techniques or conditions described in the literature in this field or follow the product specifications.
Example 1
Experimental animals: all animal experimental procedures of the study were approved by the ethical committee of animal experiments at university of Anhui medical science, SPF grade C57BL/6N mice were purchased from Experimental animal technologies, inc. of Lehua, beijing, and all mice were kept in a strictly controlled environment with the ambient humidity maintained at 50% -60% and the temperature maintained at 25+ -2deg.C for 12 hours with circadian alternation.
Experiment feed: the low-fat feed and the high-fat feed for feeding the male mice of the ancestors in the study are purchased from Nantong Talaofe feed technology Co., ltd, wherein the calorie of the low-fat feed is 10kcal, and the calorie of the high-fat feed is 60% kcal; the feed for feeding female pregnant mice and offspring mice was purchased from the company of the company australia synergetic feed, beijing, and was a common grade mouse breeding feed. The cadmium water adopts a cadmium chloride aqueous solution, and the concentration of the cadmium chloride is 100mg/L.
The implementation provides a construction method of a parent cognitive impairment animal model, which comprises the following steps:
(1) After the purchased SPF-grade C57BL/6N mice are adaptively fed for one week, 80 healthy male mice with the age of 5 weeks are selected and randomly divided into four groups, and respectively subjected to low-fat diet (Ctrl), cadmium water exposure (Cd), high-fat diet (HFD) and combined treatment of high-fat diet and cadmium water exposure (HFD+Cd); 10 weeks later mating with 10 week old female mice normally fed with normal grade mouse breeding feed at a ratio of 2:4, and the next morning, female mice with vaginal embolism were scored as pregnant for 0 days.
(2) The female pregnant mice which are successfully mated are normally eaten and naturally delivered, and the generated first generation offspring mice are adjusted to 3 male mice and female mice in each nest on the 3 rd day after birth and are fed in a lactation mode so as to ensure balanced nutrition of the mice; after the offspring mice are fed to 4 weeks of age, female and male cage separation and weaning are carried out, and each group of 20 mice are naturally fed with common grade mouse breeding feed.
(3) Naturally breeding the offspring mice to 15 weeks old, and performing Morris water maze experiment on the offspring mice; the Morris water maze experiment was stopped for 2 weeks, the offspring mice were anesthetized and sacrificed, and their hippocampal tissues were taken for pathological examination and molecular biology experiments.
1) Morris water maze experiment
The Morris water maze experiment lasted seven days in total, with the first six days being the mouse spatial learning phase and the seventh day being the mouse spatial memory phase. The specific operation is as follows: the water maze experimental operation method is established in Smart animal behavioural analysis software, the water maze area is divided into four fan-shaped areas with equal area, the platform is placed at one quadrant fixed position (the water surface is 1 cm higher than the platform), the quadrant is marked as the quadrant where the platform is located, and the other three quadrants are marked as the outer quadrants of the platform. At the beginning of the experiment, one quadrant was randomly chosen as the starting quadrant into which the mouse was placed facing the wall. After the completion, the mice are placed in the remaining three quadrants in turn, the next quadrant is selected as the starting quadrant in the clockwise direction beginning the next day, the mice are placed in the four quadrants in turn, and so on. Each quadrant was timed for 1min, the mice stopped the quadrant experiment after boarding the platform, and the next quadrant experiment was continued. After six days, the platform was removed on day seven and the mice were placed in four quadrants in sequence facing the wall, each quadrant timed for 1min. The upper platform latency, the activity course of the offspring mice in the seventh day spatial memory experiment, the upper platform latency, the activity time in the target quadrant region, the number of traversals on the platform, and the activity distance on the platform of the previous six sky-space learning experiment of the offspring mice in each experimental group were observed.
In the Morris water maze experiment process, water is replaced every two days so as to avoid the influence of water quality on the experiment result; the water temperature is detected at the beginning of each experiment, and the water temperature is ensured to be 21-22 ℃. Each mouse is dried on an electric blanket after the experiment is finished, so that the cold is avoided; the laboratory illuminance and noise were measured and recorded after the end of the experiment.
The observation results of the offspring mice are shown in fig. 1, wherein fig. 1-a is a graph showing the variation of the upper platform latency of the learning experiment between the six sky before the female offspring mice in each experimental group, and fig. 1-B, 1-C, 1-D, 1-E, 1-F are the activity route, the first platform latency crossing, the activity time in the target quadrant region, the number of times of crossing on the platform, and the activity distance on the platform of the offspring mice in the seventh day spatial memory experiment of the female offspring mice in each experimental group, respectively. FIG. 1-G is a graph showing the variation of the upper plateau latency of the study experiment between the six sky preceding the male offspring mice in each experimental group, and FIGS. 1-H, 1-I, 1-J, 1-K, 1-L are the course of activity of the offspring mice in the seventh day spatial memory experiment of the male offspring mice in each experimental group, the first crossing plateau latency, the activity time in the target quadrant region, the number of crossings on the plateau, and the distance of activity on the plateau, respectively. In fig. 1-B and 1-H, the active route pattern is the path of the mice swimming in water in the seventh day of spatial memory experiment, and the small circle in the second quadrant of the route pattern is the position where the platform is placed. Since the mouse is naturally offensive to the water environment, it will strive to find the platform and board up when it is in the water environment, after the first six days of boarding training on the platform, the normal memory mouse has developed a long-term memory for the specific location of the platform. Thus, after the platform is removed on the seventh day, the normal memory mouse's active roadmap should be immediately around the quadrant in which the platform is located (second quadrant) or repeatedly across the platform. Thus, the platform latency, the course of activity, the first time the platform latency is traversed, the time of activity in the target quadrant region, the number of traversals on the platform, and the time of traversals on the platform can be traversed by the mouseAnd comprehensively judging whether the memory of the mouse is damaged or not under the conditions of the activity distance on the table and the like. The data in FIGS. 1-C-1-F and 1-I-1-L are expressed as mean ± standard error, a P<0.05, representing comparison to a low fat diet (Ctrl) group; b P<0.05, representing a comparison with a cadmium water exposure (Cd) group.
As can be seen from the fact that the father low-fat diet (Ctrl) is taken as a control group and combined with the figures 1-A and 1-G, in the spatial learning experiment of the first six days, the combined treatment of father high-fat diet and cadmium water exposure (HFD+Cd) obviously prolongs the upper platform incubation period of female and male offspring mice. As can be seen in conjunction with fig. 1-B and 1-H, the aquatic route of the offspring mice of the father low-fat diet (Ctrl) group immediately surrounds the second quadrant and repeatedly crosses the platform, while the route of the combined treatment of father high-fat diet and cadmium water exposure (hfd+cd) group is very disordered, which illustrates that the combined exposure of father high-fat diet and cadmium water significantly impairs the memory of the offspring mice. In combination with figures 1-C-1-F and figures 1-I-1-L, it can be seen that the combined treatment of father high fat diet plus cadmium water exposure (hfd+cd) significantly increases the first pass platform latency of female and male offspring mice and reduces their time of activity in the target quadrant region, number of passes on the platform, and distance of activity on the platform in the seventh day spatial memory experiment. And the above index damage effect of the father high fat diet plus cadmium water exposure combined treatment (hfd+cd) group is further aggravated compared with the simple cadmium water exposure (Cd), high Fat Diet (HFD) group. The above experimental results demonstrate that the combination treatment of father high fat diet plus cadmium water exposure significantly reduced learning and memory in female and male offspring mice.
2) Mouse hippocampal histopathological examination and molecular biology experiments include hematoxylin-eosin (HE) staining, nikose staining, golgi staining, and synaptic related protein level detection, wherein synaptic related proteins include PSD95, synapsin-1 and BDNF.
(1) The specific operation steps of hematoxylin-eosin (HE) staining are as follows: the offspring mice are dewaxed in an oven at 55-60 ℃ for 30-35min, soaked in xylene for 3 times and 10-12min each time, hydrated by 100%, 95%, 80%, 70%, 50% and 30% alcohol each time, and dyed after soaking in distilled water for 5-6 min. The sections were stained with hematoxylin and eosin for 10-15min, then dehydrated sequentially with 30%, 50%, 70%, 80%, 95%, 100% alcohol, each stage for 2-3min, and transparent in xylene twice for 4-5min each. Finally, the plates were blocked with neutral resin, and the hippocampal neurons were observed under a microscope and counted, and the results are shown in fig. 2.
FIG. 2-A is a representative picture of hematoxylin-eosin (HE) staining of hippocampal tissue of female and male offspring mice; FIGS. 2-B, 2-C are the numbers of neurons in the hippocampal CA1, DG regions, respectively, of female offspring mice; FIGS. 2-D, 2-E are the numbers of neurons in the hippocampal CA1, DG region of male offspring mice, respectively. In fig. 2-a, the darker colored areas with a certain outline are the aggregation areas of the hippocampal neurons, the neurons after HE staining can take on dark round shapes, and the number of the hippocampal neurons can be known by quantitatively counting the neurons, and the number of the hippocampal neurons has a close relationship with the cognitive function and the neurogenesis. FIGS. 2-B, 2-C, 2-D, 2-E are results of quantifying the number of neurons in each of the groups of FIG. 2-A; and the data in figures 2-B, 2-C, 2-D, 2-E are expressed as mean + standard error, a P<0.05, representing comparison to a low fat diet (Ctrl) group; b P<0.05, representing a comparison with a cadmium water exposure (Cd) group. It can be seen that the reduction of the number of neurons in CA1 and DG regions of the hippocampus of the offspring mice is achieved by the combined treatment of the father high-fat diet and the cadmium water exposure (HFD+Cd) by taking the father low-fat diet (Ctrl) as a control group, which shows that the combined exposure of the father high-fat diet and the cadmium water damages the neurons of the hippocampus of the female and male offspring mice, thereby damaging the cognitive function.
(2) The specific operation steps of the Nib dyeing are as follows: the offspring mice are dewaxed in an oven at 55-60 ℃ for 30-35min, soaked in xylene for 3 times and 10-12min each time, hydrated by 100%, 95%, 80%, 70%, 50% and 30% alcohol each time, and dyed after soaking in distilled water for 5-6 min. Sea horse slices were stained with 0.1% cresyl violet at 37 ℃ for 10-12min; then sequentially dehydrating with 30%, 50%, 70%, 80%, 95% and 100% ethanol for 2-3min, and transparent in xylene for 4-5min each time. The method comprises the steps of carrying out a first treatment on the surface of the Finally, the pellet was sealed with neutral resin, and the hippocampal nuclei of the mice were observed under a microscope and counted, and the results are shown in fig. 3.
FIG. 3-F is a representative picture of Nile staining of hippocampal tissue of female and male offspring mice; FIGS. 3-G, 3-H are the number of nuclear-contracted neurons in the CA1 region and DG region, respectively, of the hippocampus of female offspring mice; FIGS. 3-I and 3-J show the numbers of nuclear-contracted neurons in the CA1 region and DG region, respectively, of the hippocampus of male offspring mice. In fig. 3-F, the area with a certain outline and darker color is the aggregation area of the hippocampal neurons, the neurons after being dyed by nikose also take on a dark round shape, but the neurons with the nuclear shrinkage take on a darker oval or strip shape, the number of the hippocampal nuclear shrinkage neurons can be known by quantitatively counting the neurons, and the number of the nuclear shrinkage neurons, namely the damaged neurons, is also closely related to the cognitive function and the neurogenesis. FIGS. 3-G, 3-H, 3-I, 3-J are results of quantifying the number of nuclear contractile neurons of each group of FIG. 3-F; and the data in figures 3-G, 3-H, 3-I, 3-J are expressed as mean + standard error, a P<0.05, representing comparison to a low fat diet (Ctrl) group; b P<0.05, representing a comparison with a cadmium water exposure (Cd) group. It can be seen that the combined treatment of father low-fat diet (Ctrl) and cadmium water exposure (HFD+Cd) obviously increases the number of nuclear-contracted neurons in the CA1 and DG areas of the hippocampus of the offspring mice.
(3) The specific operation steps of the Golgi dyeing are as follows: placing fresh brain tissue into a freshly prepared Golgi dye solution, and dyeing for one week; soaking brain tissue soaked in Golgi dye solution in 30% sugar water for 2 days; cutting hippocampal tissue with the thickness of 200 mu m by using an oscillation slicer, and placing the hippocampal tissue on an adhesion glass slide for subsequent staining; and sealing the slices after dyeing, finding out the neurons under a low power microscope, shooting in an enlarged mode, observing the dendritic spine density and the dendritic branch number of the neurons in different areas of the hippocampus to evaluate the development condition of the neurons of the hippocampus, and the observation result is shown in figure 4.
FIG. 4-K is a representative picture of the dendritic spines of neurons in the CA1 and DG regions of hippocampal tissue of female and male offspring mice; FIG. 4-L is the density of the dendritic spines of neurons in the CA1 and DG regions of female progeny hippocampal tissue; FIG. 4-M is the density of the neuronal dendrites of the hippocampal CA1 and DG regions of male progeny.In fig. 4-K is a dendritic spine on the secondary dendritic branch of the hippocampal neuron, which is capable of receiving and transmitting neural signals, the number density of which is closely related to brain learning and memory functions and central nervous system diseases. The density of dendritic spines is quantified as the number of dendritic spines per 10 μm length of dendritic branches. FIGS. 4-L, 4-M are results of quantifying the density of dendritic spines for each of the sets of neurons of FIG. 4-K; and the data in figures 4-L, 4-M are represented as mean + standard error, a P<0.05, representing comparison to a low fat diet (Ctrl) group; b P<0.05, representing a comparison with a cadmium water exposure (Cd) group. It can be seen that the combined treatment of father low-fat diet (Ctrl) and cadmium water exposure (HFD+Cd) obviously reduces the density of the neurons dendritic spines in the CA1 and DG areas of the hippocampus of the offspring mice, which indicates that the brain learning and memory functions of the offspring mice are reduced.
Hematoxylin-eosin (HE) staining, nikohlrabi staining and golgi staining showed that the combination treatment of father high fat diet plus cadmium water exposure significantly damaged the number and structure of hippocampal neurons in offspring mice.
(4) The protein levels of PSD95, synapsin-1 and BDNF are detected by a protein immunoblotting method, and the method comprises the following specific steps: mixing the offspring mouse hippocampal tissue with the lysate, homogenizing the mixture into liquid by using a homogenizer, centrifuging for 15min by using an ultracentrifuge 15000g, and collecting the supernatant as the total protein. Total proteins were then separated using 12.5-15% SDS-PAGE polyacrylamide gel electrophoresis and transferred to PVDF membrane. After 1-1.5h incubation with 5% skim milk, PVDF membranes were treated with PSD95, synapsin-1 and BDNF primary antibodies for 1-2 h. After the first antibody is incubated, the membrane is washed three times with membrane washing liquid for 8-10min each time, and after the membrane washing, the PVDF membrane is incubated for 1-2 hours by the second antibody. Finally, PSD95, synapsin-1 and BDNF protein levels were detected by the Bio-Rad ChemicdocTM Touch imaging system. The results are shown in FIG. 5.
FIGS. 5-A and 5-C are graphs showing the levels of PSD95, symplin-1 and BDNF proteins expressed in hippocampal tissues of female and male offspring mice, respectively, and FIGS. 5-B and 5-C are results of quantifying PSD95, symplin-1 and BDNF proteins in each of the groups of FIGS. 5-A and 5-C, respectively. The color intensity of the bands in FIGS. 5-A and 5-C represents the abundance of protein expression, and the darker the color isThe higher the protein level is shown. Three proteins, PSD95, synapsin-1 and BDNF, can influence synaptic plasticity of neurons, and are the biomolecular basis of learning and memory capacity. Thus, a decrease in the levels of these three proteins would also lead to a decrease in cognitive function. The data in figures 5-B and 5-D are expressed as mean + standard error, a P<0.05, representing comparison to a low fat diet (Ctrl) group; b P<0.05, representing a comparison with a cadmium water exposure (Cd) group. It can be seen that, by taking the father low-fat diet (Ctrl) as a control group, the combined treatment of father high-fat diet and cadmium water exposure (HFD+Cd) obviously reduces the levels of PSD95, synapsin-1 and BDNF proteins in the hippocampal tissues of female and male offspring mice, which indicates that the combined treatment of father high-fat diet and cadmium water exposure obviously damages the functions of hippocampal neurons of offspring mice.
According to the method, the father mice are subjected to combined treatment of high-fat diet and cadmium water exposure, the offspring mice are routinely bred to 15 weeks and subjected to Morris water maze test and various hippocampal pathology examination and molecular biology experiments, and as a result, the situation that the high-fat diet and cadmium water exposure combined treatment group mice have reduced learning and memory capacity, hippocampal pathology damage and reduced synaptic related protein level is found, which indicates that the father cognitive disorder model is successfully established. The modeling method is simple and easy to implement, and has strong repeatability through common verification of a plurality of indexes such as Morris water maze, golgi staining, hematoxylin-eosin (HE) staining, nishi staining, synapse-related proteins and the like.
Example 2
The present embodiment provides an application of a parental cognitive impairment animal model, in which environmental toxicants and dietary patterns are changed and applied to the animal model of example 1, the influence of candidate environmental toxicants and dietary patterns on various indexes of the animal cognitive impairment is observed, the environmental toxicants and dietary patterns with potential harm are evaluated, the mechanism of action and therapeutic targets of the parental cognitive impairment are explored, and early prevention strategies of the corresponding parental cognitive impairment are formulated.
Example 3
The present embodiment provides an application of a parental cognitive impairment animal model, wherein a candidate drug for treating cognitive impairment is applied to the animal model of example 1, and a drug capable of treating cognitive impairment is selected.
According to the method, the father mice are subjected to combined treatment of high-fat diet and cadmium water exposure, the offspring mice are routinely fed for 15 weeks and subjected to Morris water maze test and various hippocampal pathology examination and molecular biology experiments, and the result shows that the high-fat diet and cadmium water exposure combined treatment group mice have the conditions of reduced learning and memory capacity, pathological damage of the hippocampus and reduced level of synapse-related proteins, which means that a father cognitive disorder model is successfully established, the father cognitive disorder model can be used for simulating a composite exposure mode of human environmental poison and diet, the action mechanism and treatment targets of the father cognitive disorder are explored, and targeted treatment drugs of the father cognitive disorder are screened, so that important basis is provided for formulating early prevention strategies of the father cognitive disorder in future.
The above embodiments are only for illustrating the technical solution of the present application, and are not limiting; although the application has been described in detail with reference to the foregoing embodiments, it will be understood by those of ordinary skill in the art that: the technical scheme described in the foregoing embodiments can be modified or some technical features thereof can be replaced by equivalents; such modifications and substitutions do not depart from the spirit and scope of the technical solutions of the embodiments of the present application.
Claims (9)
1. A construction method of a father-source cognitive disorder animal model is characterized by comprising the following steps: the method comprises the following steps:
(1) Selecting healthy male mice of 4-6 weeks old, randomly grouping, performing high-fat diet and cadmium water exposure combined treatment on the grouped male mice, and mating the grouped male mice with normal diet female mice after 9-11 weeks;
(2) The female pregnant mice which are successfully mated are normally eaten and naturally delivered, the produced offspring mice are fed to the lactation period of 4 weeks, then the female pregnant mice are subjected to male-female cage separation and weaning, and are naturally fed according to the normal eating;
(3) Naturally breeding the offspring mice to 14-15 weeks old, and performing a behavioural experiment on the offspring mice; resting for 1-2 weeks after the behavioural experiment is finished, and carrying out anesthesia and sacrifice on offspring mice, taking sea horse tissues for pathological examination and molecular biology experiment, so as to judge the occurrence of cognitive dysfunction.
2. The method for constructing a parent cognitive impairment animal model according to claim 1, wherein: the mice exposed to the high fat diet plus cadmium water in step (1) eat 60% kcal of high fat diet.
3. The method for constructing a parent cognitive impairment animal model according to claim 1, wherein: the cadmium water in the cadmium water exposure in the step (1) adopts a cadmium chloride aqueous solution, and the concentration of the cadmium chloride is 95-105 mg/L.
4. The method for constructing a parent cognitive impairment animal model according to claim 1, wherein: the male mice and the female mice in the step (1) are SPF-grade C57BL/6N mice; and the male mice and the female mice are mated according to the proportion of 2:3-5.
5. The method for constructing a parent cognitive impairment animal model according to claim 1, wherein: and (3) 3-5 days after birth of the offspring mice generated in the step (2), adjusting the number of male mice and female mice in each nest to be the same, and feeding the offspring mice in a lactation way so as to ensure balanced nutrition of the mice.
6. The method for constructing a parent cognitive impairment animal model according to claim 1, wherein: the behavioral tests are Morris water maze, the pathological examination and molecular biology tests comprise mouse hippocampal hematoxylin-eosin staining, nile staining, golgi staining and synaptic related protein level detection, the synaptic related proteins comprise PSD95, synapsin-1 and BDNF, and the cognitive disorder of the mice is comprehensively judged through the behavioral tests and the pathological examination and molecular biology tests.
7. Use of the construction method according to claims 1-6 for simulating the complex exposure pattern of human environmental toxicants and diets and for exploring the mechanism of action and therapeutic targets of parent cognitive impairment, characterized in that: the use is for the diagnosis or treatment of non-diseases.
8. Use of the construction method according to claims 1-6 for future establishment of early prevention strategies for parent cognitive impairment, characterized in that: the use is for the diagnosis or treatment of non-diseases.
9. Use of the construction method according to claims 1-6 for the future screening of targeted therapeutic drugs for parental cognitive impairment, characterized in that: the use is for the diagnosis or treatment of non-diseases.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210861165.2A CN115500315B (en) | 2022-07-22 | 2022-07-22 | Construction method and application of father-source cognitive disorder animal model |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210861165.2A CN115500315B (en) | 2022-07-22 | 2022-07-22 | Construction method and application of father-source cognitive disorder animal model |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN115500315A CN115500315A (en) | 2022-12-23 |
| CN115500315B true CN115500315B (en) | 2023-08-29 |
Family
ID=84501686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210861165.2A Active CN115500315B (en) | 2022-07-22 | 2022-07-22 | Construction method and application of father-source cognitive disorder animal model |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115500315B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108272805A (en) * | 2018-03-07 | 2018-07-13 | 武汉大学 | A kind of construction method and application thereof of tire source property anxiety disorder rat model |
| JP2019129765A (en) * | 2018-01-31 | 2019-08-08 | 花王株式会社 | Creation method of cognitive function disorder model animal |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090143433A1 (en) * | 2004-12-01 | 2009-06-04 | Curt Hendrix | Cocktail for modulation of alzheimer's disease |
-
2022
- 2022-07-22 CN CN202210861165.2A patent/CN115500315B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2019129765A (en) * | 2018-01-31 | 2019-08-08 | 花王株式会社 | Creation method of cognitive function disorder model animal |
| CN108272805A (en) * | 2018-03-07 | 2018-07-13 | 武汉大学 | A kind of construction method and application thereof of tire source property anxiety disorder rat model |
Non-Patent Citations (1)
| Title |
|---|
| 营养因素与阿尔茨海默病的相关性研究进展;陈非;陈恳;;检验医学与临床(第05期) * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN115500315A (en) | 2022-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Geng et al. | Gut microbiota are associated with psychological stress-induced defections in intestinal and blood–brain barriers | |
| Frick et al. | Enrichment enhances spatial memory and increases synaptophysin levels in aged female mice | |
| Wiebe et al. | Prenatal tobacco exposure and self-regulation in early childhood: Implications for developmental psychopathology | |
| Hyer et al. | Chronic adolescent stress causes sustained impairment of cognitive flexibility and hippocampal synaptic strength in female rats | |
| Martin et al. | Maternal high-fat diet worsens memory deficits in the triple-transgenic (3xTgAD) mouse model of Alzheimer’s disease | |
| Kent et al. | Profiling coping strategies in male and female rats: Potential neurobehavioral markers of increased resilience to depressive symptoms | |
| Mega et al. | Paternal physical exercise demethylates the hippocampal DNA of male pups without modifying the cognitive and physical development | |
| Abozaid et al. | Developmental stage and genotype dependent behavioral effects of embryonic alcohol exposure in zebrafish larvae | |
| Royo et al. | Effects of n-3 polyunsaturated fatty acid supplementation on cognitive functions, electrocortical activity and neurogenesis in a non-human primate, the grey mouse lemur (Microcebus murinus) | |
| Facciol et al. | Developmental stage-dependent deficits induced by embryonic ethanol exposure in zebrafish: A neurochemical analysis | |
| Parvin et al. | Effects of Toxoplasma gondii infection on anxiety, depression and ghrelin level in male rats | |
| CN110506708B (en) | Mouse model for Alzheimer's disease and evaluation method | |
| Li et al. | An enriched environment delays the progression from mild cognitive impairment to Alzheimer's disease in senescence‑accelerated mouse prone 8 mice | |
| CN115500315B (en) | Construction method and application of father-source cognitive disorder animal model | |
| Li et al. | Brain structure and synaptic protein expression alterations after antidepressant treatment in a Wistar–Kyoto rat model of depression | |
| Wang et al. | Reinforcing properties of pups versus cocaine for fathers and associated central expression of Fos and tyrosine hydroxylase in mandarin voles (Microtus mandarinus) | |
| Lee et al. | Probiotics that ameliorate cognitive impairment through anti-inflammation and anti-oxidation in mice | |
| Wang et al. | Evaluation of the effects of chlorpyrifos combined with lipopolysaccharide stress on neuroinflammation and spatial memory in neonatal rats | |
| Singha et al. | Gamma aminobutyric acid signaling disturbances and altered astrocytic morphology associated with Bisphenol A induced cognitive impairments in rat offspring | |
| Ortiz-Valladares et al. | Late-emerging effects of perinatal undernutrition in neuronal limbic structures underlying the maternal response in the rat | |
| Tang et al. | Converging influence of neonatal novelty experience and maternal self-stress regulation on the plasticity of offspring acoustic startle response latency | |
| Merrill et al. | Early‐life immune activation increases song complexity and alters phenotypic associations between sexual ornaments | |
| Lang et al. | Pattern of fos activation in the ventral tegmental area (VTA) of male prairie vole’s (Microtus ochrogaster) in response to infant-related stimuli | |
| Gamble et al. | Prenatal methadone exposure leads to disruptions in adult-born dentate granule cell survival and female persistent fear responding | |
| Finesmith et al. | Prenatal ethanol exposure affects calbindin expression in an FASD mouse model |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |